P C Phillips Selected Research

P C Phillips Research Topics

Disease

15	Primitive Neuroectodermal Tumors (PNET) 01/2002 - 03/2000
14	Neoplasms (Cancer) 12/2019 - 01/2000
7	Medulloblastoma 01/2002 - 03/2000
7	Brain Neoplasms (Brain Tumor) 02/2001 - 01/2000
3	Glioma (Gliomas) 02/2001 - 09/2000
2	Necrosis 12/2019 - 01/2002
2	Neuroblastoma 06/2000 - 05/2000
1	Stroke (Strokes) 04/2007
1	Central Nervous System Neoplasms 04/2007
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2003
1	Plexiform Neurofibroma 01/2003

Drug/Important Bio-Agent (IBA)

7	Messenger RNA (mRNA)IBA 01/2002 - 03/2000
6	Biological ProductsIBA 08/2001 - 03/2000
4	Phosphotransferases (Kinase)IBA 07/2001 - 03/2000
3	Proteins (Proteins, Gene)FDA Link 01/2002 - 09/2000
3	Formaldehyde (Formol)FDA Link 04/2001 - 03/2000
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2002 - 09/2000
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2002 - 11/2001
2	Caspase 3 (Caspase-3)IBA 01/2002 - 09/2000
2	Caspase 8 (Caspase-8)IBA 01/2002 - 09/2000
2	ParaffinIBA 04/2001 - 01/2001
2	CamptothecinIBA 02/2001 - 01/2001
2	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 07/2000 - 03/2000
1	Methotrexate (Mexate)FDA LinkGeneric 12/2019
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2007
1	Thalidomide (Thalomid)FDA Link 01/2003
1	Death Domain ReceptorsIBA 01/2002
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2001
1	Vascular Endothelial Growth FactorsIBA 11/2001
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2001
1	Transforming Growth Factor alpha (TGF-alpha)IBA 11/2001
1	Endothelial Growth FactorsIBA 11/2001
1	platelet-derived growth factor AIBA 11/2001
1	Vascular Endothelial Growth Factor CIBA 11/2001
1	Vascular Endothelial Growth Factor BIBA 11/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2001
1	p38 Mitogen-Activated Protein KinasesIBA 07/2001
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 07/2001
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2001
1	JNK Mitogen-Activated Protein KinasesIBA 07/2001
1	temsirolimus FDA Link 02/2001
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2001
1	Sirolimus (Rapamycin)FDA Link 02/2001
1	Cisplatin (Platino)FDA LinkGeneric 02/2001
1	CyclinsIBA 01/2001
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2001
1	Cyclin AIBA 01/2001
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2001
1	Cyclin B1IBA 01/2001
1	Topoisomerase I InhibitorsIBA 01/2001
1	Decitabine FDA Link 09/2000
1	MethyltransferasesIBA 09/2000
1	Nerve Growth Factors (Neurotrophins)IBA 07/2000
1	RNA (Ribonucleic Acid)IBA 06/2000
1	NitrogenIBA 06/2000
1	SolutionsIBA 06/2000
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2000
1	Tetracycline (Achromycin)FDA LinkGeneric 05/2000
1	Complementary DNA (cDNA)IBA 05/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2000
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2000
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2000

Therapy/Procedure

4	Therapeutics 12/2019 - 01/2000
2	Radiotherapy 12/2019 - 04/2000
2	Aftercare (After-Treatment) 12/2019 - 01/2001
2	Drug Therapy (Chemotherapy) 01/2001 - 05/2000
1	Proton Therapy 12/2019
1	Combination Drug Therapy (Combination Chemotherapy) 02/2001
1	Cranial Irradiation 04/2000